Hungnes O - Search Results

1

Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.

Fossum E, Rohringer A, Aune T, Rydland KM, Bragstad K, Hungnes O. Fossum E, et al. Among authors: hungnes o. Virol J. 2024 Mar 6;21(1):57. doi: 10.1186/s12985-024-02326-w. Virol J. 2024. PMID: 38448981 Free PMC article.

2

Interference between outbreaks of epidemic viruses.

Anestad G, Vainio K, Hungnes O. Anestad G, et al. Among authors: hungnes o. Scand J Infect Dis. 2007;39(6-7):653-4. doi: 10.1080/00365540701253860. Scand J Infect Dis. 2007. PMID: 17577842 No abstract available.

3

[AIDS--possibilities for vaccine and antiviral therapy].

Grinde B, Hungnes O, Tjøtta E. Grinde B, et al. Among authors: hungnes o. Tidsskr Nor Laegeforen. 1988 Jun 20;108(17-18):1413-5. Tidsskr Nor Laegeforen. 1988. PMID: 3388373 Norwegian. No abstract available.

4

Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.

Meijer A, Brown C, Hungnes O, Schweiger B, Valette M, van der Werf S, Zambon M; Virology Task Groups of the European Influenza Surveillance Scheme. Meijer A, et al. Among authors: hungnes o. Vaccine. 2006 Nov 10;24(44-46):6717-23. doi: 10.1016/j.vaccine.2006.05.068. Epub 2006 Jun 5. Vaccine. 2006. PMID: 16782242

5

Perforated hepatocytes as a system for studying intracellular proteolysis.

Grinde B, Hungnes O, Gravningen M. Grinde B, et al. Among authors: hungnes o. Biomed Biochim Acta. 1986;45(11-12):1627-33. Biomed Biochim Acta. 1986. PMID: 3555477

6

Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s.

Jonassen TO, Stene-Johansen K, Berg ES, Hungnes O, Lindboe CF, Frøland SS, Grinde B. Jonassen TO, et al. Among authors: hungnes o. Virology. 1997 Apr 28;231(1):43-7. doi: 10.1006/viro.1997.8510. Virology. 1997. PMID: 9143301 Free article.

7

High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors.

Huang LY, Oystein Jonassen T, Hungnes O, Grinde B. Huang LY, et al. Among authors: hungnes o. J Med Virol. 2001 Jul;64(3):381-6. doi: 10.1002/jmv.1062. J Med Virol. 2001. PMID: 11424130

8

Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end.

Hungnes O. Hungnes O. Vaccine. 2006 Nov 10;24(44-46):6694-6. doi: 10.1016/j.vaccine.2006.05.045. Epub 2006 Jun 8. Vaccine. 2006. PMID: 16920231

9

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Hauge SH, et al. Among authors: hungnes o. Emerg Infect Dis. 2009 Feb;15(2):155-62. doi: 10.3201/eid1502.081031. Emerg Infect Dis. 2009. PMID: 19193257 Free PMC article.

10

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.

Hauge SH, Blix HS, Borgen K, Hungnes O, Dudman SG, Aavitsland P. Hauge SH, et al. Among authors: hungnes o. Virol J. 2009 May 12;6:54. doi: 10.1186/1743-422X-6-54. Virol J. 2009. PMID: 19435505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters